Tag Archive: T cells

Aug 31 2017

A Moment to Remember: First-of-its-Kind Cancer Treatment Approved by FDA

It was a pivotal moment that has turned into a new era for cancer immunotherapy. On April 17, 2012, Children’s Hospital of Philadelphia researchers for the first time treated a pediatric patient with a cellular therapy that used her own reprogrammed immune cells, called T cells, to attack her aggressive form of blood cancer.

Permanent link to this article: http://blog.research.chop.edu/moment-remember-first-kind-cancer-treatment-approved-fda/

Apr 21 2016

Putting the Brakes on Allergic Response

When you have a chronic allergic disorder, it’s easy to blame the trigger — an early pollen season or furry pet — but the real culprit is your own immune system. Designed to attack foreign substances such as bacteria and viruses, T cells are the immune system’s watchdog to recognize serious threats. But sometimes T cells can be too zealous and set in motion a signaling cascade that can cause allergic reactions to everyday things and even attack your body’s healthy cells by mistake.

Permanent link to this article: http://blog.research.chop.edu/putting-brakes-allergic-response/

Sep 17 2015

Teaching the Immune System to Have Long-term Memory for Leukemia

Your immune system is designed to protect against foreign invaders such as infections, but you may not realize that it also destroys abnormal cells that your body produces.

Permanent link to this article: http://blog.research.chop.edu/teaching-the-immune-system-to-have-long-term-memory-for-leukemia/

May 08 2015

Cookies for Kids’ Cancer Funds Support Rapid Discovery of New Therapies

Cookies for Kids’ Cancer, a nonprofit foundation dedicated to pediatric cancer research, uses the proceeds from its cookie sales and other fundraising events to provide grants to support the work of scientists at five of the nation’s leading pediatric cancer centers.

Permanent link to this article: http://blog.research.chop.edu/cookies-for-kids-cancer-funds-support-rapid-discovery-of-new-therapies/

Dec 19 2014

Benefits Persist in T Cell Therapy for Children with Relapsed Leukemia

An innovative cell therapy for this stubborn form of leukemia continues to show highly promising results in children treated in a pilot clinical trial.

Permanent link to this article: http://blog.research.chop.edu/benefits-persist-t-cell-therapy-children-relapsed-leukemia/

Dec 09 2013

Groundbreaking Leukemia Research Featured at ASH Annual Meeting

The Children’s Hospital of Philadelphia’s groundbreaking leukemia research was on display at the recent American Society of Hematology (ASH) Annual Meeting. Held in New Orleans, the ASH Annual Meeting brought together approximately 20,000 researchers, clinicians, and industry representatives, with data from more than 5,300 abstracts presented.  Notably, Children’s Hospital’s Stephan A. Grupp, MD, PhD, co-chaired …

Continue reading »

Permanent link to this article: http://blog.research.chop.edu/groundbreaking-leukemia-research-featured-ash-annual-meeting/

Nov 19 2013

CHOP Cancer Researcher, Patient Named WebMD Health Heroes

The Children’s Hospital of Philadelphia’s Stephan A. Grupp, MD, PhD, along with his young patient Emily Whitehead, were recently named 2013 WebMD Health Heroes.

Permanent link to this article: http://blog.research.chop.edu/chop-cancer-researcher-patient-named-webmd-health-heroes/

Sep 10 2013

Groundbreaking Immune Therapy Featured on 60 Minutes Australia

The groundbreaking immune therapy work being done by The Children’s of Hospital of Philadelphia’s Stephen M. Grupp, MD, PhD, was recently highlighted on Australia’s 60 Minutes.

Permanent link to this article: http://blog.research.chop.edu/groundbreaking-immune-therapy-featured-60-minutes-australia/

Mar 07 2013

CHOP Researcher’s Innovative Immune Therapy Featured on The Doctors

The innovative work being done by CHOP’s Stephen Grupp, MD, was recently featured on the CBS show The Doctors. Dr. Grupp, the Center for Childhood Cancer Research’s director of translational research, discussed his trial using immune therapy to treat an aggressive form of childhood leukemia, acute lymphoblastic leukemia (ALL). While roughly 85 percent of ALL …

Continue reading »

Permanent link to this article: http://blog.research.chop.edu/chop-researchers-innovative-immune-therapy-featured-on-the-doctors/